3
Announcements
Trials
Browse
Landscape
Status
Completed
24
Terminated
9
Active not recruiting
9
Recruiting
6
Unknown
5
No longer available
2
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma
7
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Recurrence
3
Pain
3
Lymphoma, B-Cell
3
Hematologic Neoplasms
3
Anxiety Disorders
3
Prostatic Neoplasms
2
Lymphoproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, B-Cell
2
Leukemia
2
Irritable Bowel Syndrome
2
Hypertension
2
Hodgkin Disease
2
Depression
2
Dementia
2
Cognitive Dysfunction
2
Atrial Fibrillation
2
Asthma
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Immunoproliferative Disorders
×
Lymphoid
×
Clear all
NCT04996706
2026-05-26
LEO
Mayo Clinic
Enrolling by invitation
21,000 enrolled